| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,664 | 27,752 | 14,635 | 4,655 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 27,752 | 14,635 | 4,655 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (57,438) | 49,503 | (1,880) | (171,531) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 82,377 | (21,751) | 16,515 | 176,186 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (36,908) | 45,414 | (1,329) | 3,801 | | Earnings Before Interest And Taxes | 52,194 | 23,932 | 14,917 | 179,987 | | Interest Expense | 4,262 | 4,675 | 4,965 | 4,492 | | Income Before Tax | 47,932 | 19,257 | 9,952 | 175,495 | | Income Tax Expense | 2,660 | (23) | (618) | 33,465 | | Minority Interest | (20,318) |
-
|
-
| (46,703) | | | | Net Income From Continuing Ops | 45,003 | 19,280 | 10,839 | 95,126 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,150 | 19,280 | 10,839 | 95,126 | | Preferred Stock And Other Adjustments | 9,837 | (10,529) | 692 |
-
| | | Net Income Applicable To Common Shares | $34,987 | $8,751 | $11,531 | $95,126 |
|
1.48% Nasdaq 
Income Statement
